NEW YORK (GenomeWeb) – Rainbow Genomics said today that it is partnering with Color to provide hereditary cancer and heart health genetic risk assessment tests in Hong Kong. Rainbow, a preferred partner of Color in Hong Kong, will offer that firm's genetic tests for the analysis of a patient's risk for eight hereditary cancers and four hereditary heart health conditions. The partnership, Rainbow said, will provide a fully integrated solution for actionable clinical test results at an affordable price point, though it did not elaborate.
Rainbow Genomics is to offer Californian firm Color Genomics' genetic tests to users in US, testing for eight hereditary cancers and four hereditary heart health conditions. Given the region's "chronic shortage" of genetic counsellors and prohibitive cost associated with such testing, Rainbow CEO Daniel Siu said the collaboration was a "significant step" towards enabling anyone to be tested for genetic risk to inherited conditions. The announcement follows Rainbow Genomics' earlier indication that it was looking to partner with Hong Kong firms to offer genetic testing in Asia.